Skip to main content
$3.18 $0.05 (1.6%)

04:00 PM EDT on 09/29/22

Co-Diagnostics, Inc. (NASDAQ:CODX)

CAPS Rating: 1 out of 5

Current Price $3.18 Mkt Cap $105.7M
Open $3.08 P/E Ratio 2.33
Prev. Close $3.18 Div. (Yield) $0.00 (0.0%)
Daily Range $3.08 - $3.24 Volume 292,823
52-Wk Range $2.76 - $10.90 Avg. Daily Vol. 634,914

Caps

How do you think NASDAQ:CODX will perform against the market?

Add Stock to CAPS Watchlist

All Players

37 Outperform
36 Underperform
 

All-Star Players

5 Outperform
27 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:CODX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

peacemaker01 (44.62)
Submitted April 19, 2020

CODX is a frontrunner in diagnostic tests for covid19.

joaquingrech (97.80)
Submitted March 27, 2020

it may surge now but long term i just don't see it, only 1 product and easy to replicate

NASDAQ:CODX Summary

Fools bullish on NASDAQ:CODX are also bullish on:

Fools bearish on NASDAQ:CODX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about CODX.

Recs

0
Member Avatar BuyouTech (< 20) Submitted: 5/13/2021 5:42:16 PM : Outperform Start Price: $7.49 NASDAQ:CODX Score: -40.72

Tiny $200M market cap biotech that is already profitable. No debt and 50% margins. Has patented co-primer technology that works with both DNA and RNA. Approx. 50% International sales of Covid 19 PCR test. Pursuing a broad range of clinical testing possibilities including liquid biopsy cancer detection and direct to consumer Covid testing.

Recs

0
Member Avatar Kentuckyfarmer (< 20) Submitted: 1/15/2021 7:22:08 AM : Outperform Start Price: $10.13 NASDAQ:CODX Score: -64.91

Increased revenue in 2020 was due to covid-19 testing and that was just what the company needed to finally become profitable. They have many other test capabilities if Covid-19 tests go away. They are also involved in the agricultural field which is another interesting avenue for growth in the future. Small cap with lots of room to run

Recs

0
Member Avatar TMFbonefish (36.23) Submitted: 1/12/2021 7:09:04 PM : Outperform Start Price: $10.42 NASDAQ:CODX Score: -65.28

Intellectual property that results in better product performance in a fast-growing competitive space is a recipe for getting acquired or being in a position to take share from others. Applications in agriculture are also intriguing.

Leaderboard

Find the members with the highest scoring picks in CODX.

Score Leader

copetom

copetom (42.39) Score: +426.68

Due to the panic over covid-19 I marked it as outperform. Which it did for a few days. I have since sold it, NVAX, INO, and 2 others. Nice profit on NVAX especially.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Toprope101 99.89 3/12/2020 Underperform 5Y $12.76 -75.08% +41.72% +116.80 0 Comment
RayNobleEsq 99.98 4/21/2020 Underperform 5Y $13.46 -76.37% +32.00% +108.38 0 Comment
joaquingrech 97.80 3/27/2020 Underperform 5Y $9.19 -65.40% +41.97% +107.36 1 Comment
cvdynasty0 99.94 4/16/2020 Underperform 5Y $11.28 -71.81% +30.85% +102.65 0 Comment
dinasourneil 99.57 3/6/2020 Underperform 1Y $14.23 -77.65% +23.83% +101.48 0 Comment
NorteClub 84.65 7/29/2020 Underperform 5Y $22.14 -85.64% +12.63% +98.27 0 Comment
chrispycrunch 91.42 3/5/2020 Underperform 5Y $14.65 -78.29% +19.10% +97.39 0 Comment
kdakota630 36.71 4/17/2020 Underperform 3M $10.20 -68.82% +27.13% +95.96 0 Comment
ClientNein 100.00 7/17/2020 Underperform 5Y $17.75 -82.08% +12.73% +94.81 0 Comment
evergreen5555 68.45 9/5/2017 8/20/2022 Underperform NS $5.91 -46.19% +47.77% +93.96 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CODX.